Salivary Cytokines, MMP-8 and Dental Caries in Osteoporosis Patients
Osteoporoz Hastalarında Tükürük Sitokin, Matrix Metalloproteinase 8 ve Diş Çürüğünün Değerlendirilmesi
1 other identifier
observational
50
0 countries
N/A
Brief Summary
This study examines saliva samples from patients with osteoporosis. The levels of cytokines and Matrix Metalloproteinase-8 (MMP-8) enzyme in saliva will be measured. Additionally, the dental caries status of participants will be evaluated. The aim of this study is to understand the relationship between osteoporosis and oral health. Only saliva samples will be collected from participants; no treatment or medication will be administered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2026
CompletedFirst Submitted
Initial submission to the registry
July 12, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 10, 2027
July 16, 2026
July 1, 2026
3 months
July 12, 2026
July 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Salivary Cytokine Levels
Measurement of cytokine levels in saliva samples collected from osteoporosis patients
day 1
Study Arms (2)
Osteoporosis Group
Patients diagnosed with osteoporosis. Saliva samples will be collected to measure cytokine levels and MMP-8.
Control Group
Healthy individuals without osteoporosis. Saliva samples will be collected for comparison.
Eligibility Criteria
Patients diagnosed with osteoporosis who applied to the outpatient clinic. Saliva samples and dental caries status will be evaluated. Participants will be selected according to inclusion and exclusion criteria.
You may qualify if:
- Willing to give voluntary consent For Group 1, having been diagnosed with osteoporosis For Group 2, being systemically healthy and not having a diagnosis of osteoporosis/osteopenia
You may not qualify if:
- Having a chronic inflammatory or autoimmune disease Using glucocorticoids, anti-anxiety medications, antidepressants, or antiepileptic drugs Having been diagnosed with any malignancy Having any endocrine disease Having undergone periodontal treatment within the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 12, 2026
First Posted
July 16, 2026
Study Start
July 10, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
July 10, 2027
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share